Aerie Pharmaceuticals
Innovative ophthalmic therapies for glaucoma, dry eye, and retinal diseases. Learn more
Launch date
Employees
Market cap
€685m
Enterprise valuation
€835m (Public information from Nov 2022)
Share price
$15.25 AERI
Durham North Carolina (HQ)
Authorizing premium user...